APOBEC3B Antikörper (N-Term)
-
- Target Alle APOBEC3B Antikörper anzeigen
- APOBEC3B (Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3B (APOBEC3B))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser APOBEC3B Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF), Immunocytochemistry (ICC)
- Spezifität
- APOBEC3D/F Antibody detects endogenous levels of total APOBEC3D/F.
- Aufreinigung
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
- Immunogen
- A synthesized peptide derived from human APOBEC3D/F, corresponding to a region within N-terminal amino acids.
- Isotyp
- IgG
-
-
- Applikationshinweise
- WB 1:500-1:1000, IHC: 1:50-1:200, IF/ICC 1:100-1:500, ELISA(peptide) 1:20000-1:40000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C. Stable for 12 months from date of receipt.
- Haltbarkeit
- 12 months
-
- Target
- APOBEC3B (Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3B (APOBEC3B))
- Andere Bezeichnung
- APOBEC3D,APOBEC3F (APOBEC3B Produkte)
- Synonyme
- A3B antikoerper, APOBEC1L antikoerper, ARCD3 antikoerper, ARP4 antikoerper, DJ742C19.2 antikoerper, PHRBNL antikoerper, bK150C2.2 antikoerper, APOBEC3B antikoerper, Apobec3 antikoerper, Apobec3f antikoerper, APOBEC3F antikoerper, APOBEC3Z2 antikoerper, APOBEC3Z3 antikoerper, apolipoprotein B mRNA editing enzyme catalytic subunit 3B antikoerper, APOBEC3B antikoerper, Apobec3b antikoerper
- Hintergrund
-
Description: DNA deaminase (cytidine deaminase) which acts as an inhibitor of retrovirus replication and retrotransposon mobility via deaminase-dependent and -independent mechanisms. Exhibits antiviral activity against vif-deficient HIV-1. After the penetration of retroviral nucleocapsids into target cells of infection and the initiation of reverse transcription, it can induce the conversion of cytosine to uracil in the minus-sense single-strand viral DNA, leading to G-to-A hypermutations in the subsequent plus-strand viral DNA. The resultant detrimental levels of mutations in the proviral genome, along with a deamination-independent mechanism that works prior to the proviral integration, together exert efficient antiretroviral effects in infected target cells. Selectively targets single-stranded DNA and does not deaminate double-stranded DNA or single-or double-stranded RNA. May inhibit the mobility of LTR and non-LTR retrotransposons.
Gene: APOBEC3D
- Molekulargewicht
- 40 kDa
- Gen-ID
- 200316
- UniProt
- Q96AK3, Q8IUX4
-